Eli Lilly, one of the world’s largest pharmaceutical companies, invites designers and developers to re-imagine clinical trial information in a patient-centric way. As part of Lilly’s Clinical Open Innovation initiative, which calls on open innovation to help transform clinical research and development, challenge participants are now being asked to focus on the ideas and possibilities for envisioning clinical trial protocols from a patient’s point of view.

Clinical trial information can often be dense and difficult to digest from a patient’s perspective. Patients may have questions surrounding the risks and benefits of their participation in the trial, logistics, the role of their personal doctor, and much more.  The goal for this challenge is to redesign that information in a way that highlights key aspects in a visually appealing and user-friendly way.

Submissions will take the form of design mockups and participants will be asked to submit one or more images, or browser viewable files, that incorporate key sections found in the Required Sections and Fields document and also use content data from the provided sample clinical trial documents.

Click “Register” for submission requirements and eligibility details.

Eligibility

Participants: Individuals at least the age of majority in their jurisdiction of residence at the time of entry; Teams of eligible individuals; Organizations (up to 50 employees).

Large Organization Participants: Organizations with over 50 employees may compete for the non-cash Large Organization Recognition Award.

Complete Eligibility Requirements

Requirements

What to create: One or more image or browser viewable files that incorporate all required data fields found in the Required Sections and Fields document and uses content from the provided sample clinical trial documents. (Acceptable formats: PNG, JPG, GIF – non-animated, TIFF, PSD, AI, PDF, or HTML.)

Licensing: All submitted designs must be made publicly available through the Creative Commons Attribution 3.0 Unported License

Platforms: Submissions should be designed in a way that is ultimately implementable using HTML, CSS, and JavaScript. Submitting a working software applicaton of the design is optional for this competition, but not required.

Complete Eligibility Requirements

Hackathon Sponsors

Prizes

$75,000 in prizes

Grand Prize

Second Prize

Third Prize

Honorable Mention (3)

Popular Choice

Large Organization Recognition Award

Non-cash, recognition only

Devpost Achievements

Submitting to this hackathon could earn you:

How to enter

  1. Click “Register” to sign up for important challenge updates.
  2. Review the Resources page to get access to the Required Sections and Fields document and the required content.
  3. Create your design (Acceptable formats: PNG, JPG, GIF – non-animated, TIFF, PSD, AI, PDF, or HTML.)
  4. Confirm you have read and agree to the Official Rules and are releasing your design to the public under the Creative Commons Attribution 3.0 Unported License, then submit your design by completing the submission form.

Judges

Newt Crenshaw

Newt Crenshaw
VP Oncology Business Unit, Eli Lilly

Sharon Terry

Sharon Terry
CEO, Genetic Alliance

Jeri Burtchell

Jeri Burtchell
Patient Advocate and Co-Founder, www.PartnersInResearch.org

Regina Holiday

Regina Holiday
Patient Advocate

Esther Dyson

Esther Dyson
Chairman, HICCup

Ross Kimbarovsky

Ross Kimbarovsky
Co-founder - crowdSPRING

Rahlyn Gossen

Rahlyn Gossen
Founder, Rebar Interactive

Annette Diefenthaler

Annette Diefenthaler
Senior Design Researcher and Project Lead, IDEO

Judging Criteria

  • Visual Presentation
    Includes visual appeal, and whether the hierarchy and density of information is user-friendly and digestible.
  • Patient Usefulness
    Includes whether the design highlights information valuable to patients and assists them in options for their next steps in health care.
  • Appropriateness for Mobile or Web Application
    Includes the potential to implement the design as a mobile or web app.
  • Potential Impact on Clinical Trials
    Includes the extent to which the submission may enrich the clinical trial experience for patients, caregivers, and medical institutions.

Tell your friends

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.